Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

GENBGenerate Biomedicines, Inc.

Nasdaq · CIK 0002100782
Filer category<br>Emerging growth company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts124

Identity from submissions API

NameGenerate Biomedicines, Inc.
CIK0002100782
TickersGENB
ExchangesNasdaq
Entity typeoperating
Category<br>Emerging growth company
SIC2834 Pharmaceutical Preparations
EIN831630228
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone888-469-0055
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
101 SOUTH STREET, SUITE 900
SOMERVILLE
MA
02143
MA
Mailing address
101 SOUTH STREET, SUITE 900
SOMERVILLE
MA
02143
MA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

58 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-12 8-K 8-K 2.02,9.01 0001193125-26-456921 001-43165 261543158 34 563715 1 1
2026-11-12 10-Q 10-Q 0001193125-26-456890 001-43165 261543103 34 12300751 1 1
2026-11-05 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000315066-26-002749 005-95695 261526163 34 11357
2026-11-04 4 4 0001193125-26-447199 6413
2026-10-29 144 xsl144X01/primary_doc.xml 0001959173-26-007553 001-43165 261501945 33 5539
2026-09-03 4 4 0001193125-26-381875 6411
2026-09-02 144 xsl144X01/primary_doc.xml 0001959173-26-006666 001-43165 261355093 33 4982
2026-09-01 144 xsl144X01/primary_doc.xml 0001959173-26-006611 001-43165 261351207 33 4343
2026-08-26 8-K 8-K 7.01,9.01 0001193125-26-365556 001-43165 261317238 34 1231195 1 1
2026-08-06 10-Q 10-Q 0001193125-26-336437 001-43165 261245649 34 11712040 1 1
2026-08-06 8-K 8-K 2.02,9.01 0001193125-26-336462 001-43165 261245646 34 544560 1 1
2026-05-15 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001193125-26-226574 005-95695 26986560 34 117377
2026-05-15 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001193125-26-225441 005-95695 26982600 34 6820
2026-05-07 10-Q 10-Q 0001193125-26-210059 001-43165 26950575 34 10648505 1 1
2026-05-07 8-K 8-K 2.02,9.01 0001193125-26-209899 001-43165 26950564 34 417836 1 1
2026-03-12 3 3 0000950130-26-000106 4785
2026-03-06 4 4 0001193125-26-096799 6324
2026-03-02 4 4 0001193125-26-085952 5238
2026-03-02 4 4 0001193125-26-085939 6822
2026-03-02 4 4 0001193125-26-085928 5132
2026-03-02 4 4 0001193125-26-085911 5299
2026-03-02 4 4 0001193125-26-085910 5304
2026-03-02 4 4 0001193125-26-085903 5182
2026-03-02 4 4 0001193125-26-085898 12040
2026-03-02 4 4 0001193125-26-085888 56978
2026-03-02 4 4 0001193125-26-085886 7559
2026-03-02 4 4 0001193125-26-085883 13345
2026-03-02 4 4 0001193125-26-085881 10308
2026-03-02 4 4 0001193125-26-085872 6579
2026-03-02 4 4 0001193125-26-085871 5239
2026-03-02 4 4 0001193125-26-085861 5130
2026-03-02 4 4 0001193125-26-085855 54950
2026-03-02 8-K 8-K 5.03,9.01 0001193125-26-085780 001-43165 26709491 34 479436 1 1
2026-02-27 S-8 S-8 0001193125-26-083253 333-293898 26702028 33 300682 1 1
2026-02-27 424B4 424B4 0001193125-26-083190 333-293204 26701809 33 51511795
2026-02-26 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-000677 333-293204 26692324 33 1735
2026-02-26 3 3 0001193125-26-078748 34358
2026-02-26 3 3 0001193125-26-078738 32272
2026-02-26 3 3 0001193125-26-078483 25782
2026-02-26 3 3 0001193125-26-078427 21902
2026-02-26 3 3 0001193125-26-078419 20327
2026-02-26 3 3 0001193125-26-078415 17432
2026-02-26 3 3 0001193125-26-078413 19320
2026-02-26 3 3 0001193125-26-078412 21588
2026-02-26 3 3 0001193125-26-078405 15995
2026-02-26 3 3 0001193125-26-078404 23721
2026-02-26 3 3 0001193125-26-078397 20452
2026-02-26 3 3 0001193125-26-078395 24245
2026-02-26 3 3 0001193125-26-078385 19380
2026-02-26 3 3 0001193125-26-078381 15610
2026-02-26 3 3 0001193125-26-078355 23770
2026-02-26 3 3 0001193125-26-078349 17709
2026-02-26 CERT GENB_8A_Cert_2100782.pdf 0001354457-26-000222 001-43165 26686924 34 583503
2026-02-24 8-A12B 8-A12B 0001193125-26-067219 001-43165 26672219 34 40871
2026-02-23 S-1/A S-1/A 0001193125-26-062362 333-293204 26662014 33 54289989 1 1
2026-02-13 S-1/A S-1/A 0001193125-26-051761 333-293204 26634546 33 2646277
2026-02-04 S-1 S-1 0001193125-26-037799 333-293204 26599235 33 61503015 1 1
2025-12-23 DRS filename1.htm 0001193125-25-330964 377-08875 251600805 33 54180508

Latest XBRL company facts

One latest value per concept from companyfacts (124 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 129.10M 2026-10-29 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 7.89M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 1.10M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 58.45M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -264,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 1.27B 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 8.06M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 22.69M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 23.57M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap Assets Assets USD 515.89M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap AssetsCurrent Assets, Current USD 414.64M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 0 2025-12-31 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets USD 600,000 2023-06-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities USD 2.10M 2023-06-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 720,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 140.35M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 404.20M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 144.38M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 18.35M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 30.86M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 500.00M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 129.02M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 129.02M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap CommonStockValue Common Stock, Value, Issued USD 129,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -216.73M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest USD -268,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest USD -217.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap ConvertiblePreferredStockSharesIssuedUponConversion Convertible Preferred Stock, Shares Issued upon Conversion shares 69.33M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months USD 266,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Number of Positions Holding 61 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 7.95M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap DeferredRevenueNoncurrent Deferred Revenue, Noncurrent USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 10.19M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap DepreciationNonproduction Depreciation, Nonproduction USD 10.19M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -2.09 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -2.09 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 11.02M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD 363,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers Into Level 3 USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers out of Level 3 USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap FinanceLeaseLiabilityCurrent Finance Lease, Liability, Current USD 12.50M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap FinanceLeaseLiabilityNoncurrent Finance Lease, Liability, Noncurrent USD 5.89M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap FinanceLeasePrincipalPayments Finance Lease, Principal Payments USD 3.46M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap ForeignCurrencyTransactionGainLossBeforeTax Foreign Currency Transaction Gain (Loss), before Tax USD -62,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 40.59M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap HeldToMaturitySecuritiesFairValue Debt Securities, Held-to-maturity, Fair Value USD 183.95M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -216.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 130,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 4.04M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 2.75M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD -17.76M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -6.86M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap IncreaseDecreaseInOtherNoncurrentLiabilities Increase (Decrease) in Other Noncurrent Liabilities USD -116,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD 2.55M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD -2.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 529,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 11.69M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap InvestmentIncomeNetAmortizationOfDiscountAndPremium Investment Income, Net, Amortization of Discount and Premium USD 987,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap Liabilities Liabilities USD 134.73M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 515.89M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap LiabilitiesCurrent Liabilities, Current USD 82.72M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap MarketableSecuritiesCurrent Marketable Securities, Current USD 263.86M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap MinorityInterest Stockholders' Equity Attributable to Noncontrolling Interest USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 381.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -170.27M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -193.19M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -216.36M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap NetIncomeLossAttributableToNoncontrollingInterest Net Income (Loss) Attributable to Noncontrolling Interest USD -268,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -224.11M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 10.74M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap OperatingExpenses Operating Expenses USD 244.99M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -227.23M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 10.83M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 46.12M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 53.26M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 9.34M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD -370,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 3.16M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 469.29M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 6.87M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap PreferredStockConvertibleSharesIssuable PreferredStockConvertibleSharesIssuable shares 69.33M 2025-12-31 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.001 2026-03-02 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-03-02 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 10.43M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 369.29M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap ProceedsFromIssuanceOfConvertiblePreferredStock Proceeds from Issuance of Convertible Preferred Stock USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap ProceedsFromMinorityShareholders Proceeds from Noncontrolling Interests USD 7.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap ProceedsFromSaleAndMaturityOfMarketableSecurities Proceeds from Sale and Maturity of Marketable Securities USD 305.89M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 8.47M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -216.63M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 97.10M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 38.65M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross Research and Development Arrangement, Contract to Perform for Others, Costs Incurred, Gross USD 73.21M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 204.40M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap RestrictedCashAndCashEquivalents Restricted Cash and Cash Equivalents USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap RestrictedCashAndCashEquivalentsAtCarryingValue Restricted Cash and Cash Equivalents, Current USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap RestrictedCashAndCashEquivalentsNoncurrent Restricted Cash and Cash Equivalents, Noncurrent USD 4.03M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -892.65M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 17.76M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability Right-of-Use Asset Obtained in Exchange for Finance Lease Liability USD 14.17M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap SegmentReportingOtherItemAmount SegmentReportingOtherItemAmount USD 425,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 22.69M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.823 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.037 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 381.16M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 0.658 2026-02-01 2026-02-28 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 811.83M 2026-01-01 2026-03-31 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 369.29M 2026-01-01 2026-03-31 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures USD 46,000 2025-01-01 2025-03-31 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 4.85M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap TemporaryEquityDividendsAdjustment Temporary Equity, Dividends, Adjustment USD 7.75M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap TemporaryEquityLiquidationPreference Temporary Equity, Liquidation Preference USD 960.45M 2025-12-31 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap TemporaryEquitySharesAuthorized Temporary Equity, Shares Authorized shares 113.96M 2025-12-31 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap TemporaryEquitySharesIssued Temporary Equity, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap TemporaryEquitySharesOutstanding Temporary Equity, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 107.44M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 107.44M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456890

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →